Genitourinary malignancy among patients presenting with microscopic hematuria in Northwestern Ontario

Authors

  • Shahrzad Keramati
  • Ahmed Mousa
  • Moustafa Fathy
  • Vahid Mehrnoush
  • Mark Tatangelo
  • Neda Ghaffarimarandi
  • Salima Oukachbi
  • Mohammed Bassuony
  • Farah Labib
  • Dina S. Shaker
  • Abdalla Bazazo
  • Ahmed S. Zakaria
  • Ahmed Kotb
  • Kristen Morin
  • David Marsh
  • Hazem Elmansy

DOI:

https://doi.org/10.5489/cuaj.9469

Keywords:

Genitourinary cancer, Microscopic Hematuria, Ontario

Abstract

Introduction: Microscopic hematuria (MH) may indicate an underlying genitourinary (GU) malignancy. Accordingly, MH workup is essential to mitigate GU cancer-related morbidity and mortality. This study aimed to evaluate the etiologies of MH in Northwestern Ontario, Canada.

Methods: We conducted a retrospective cohort chart review of 2545 patients referred to our institution for MH from 20102020. Demographic and clinical data were collected. Low- and high-grade MH were defined as ≤25 and >25 red blood cells (RBCs) per high-power field (HPF), respectively.

Results: The prevalence of GU cancer was 5.2% among patients with MH; the majority of cases (108/133, 81.2%) were identified during the initial workup, with urothelial carcinoma of the bladder being the most common subtype (81.2%). GU cancer was significantly associated with male sex (odds ratio [OR] 2.958, p<0.001), older age (OR 1.033, p<0.001), history of gross hematuria (GH) occurring more than 12 months prior (OR 3.469, p<0.001), prior lower urinary tract symptoms (LUTS, OR 0.081, p=0.014), and high-grade MH (>25 RBC/HPF, OR 2.977, p<0.001). High-grade GU cancer was significantly associated with male sex (OR 3.012, p<0.001), older age (OR 1.033, p<0.001), prior GH (OR 4.195, p<0.001), and history of LUTS (OR 0.088, p=0.016).

Conclusions: In our cohort, the prevalence of GU malignancy among patients with MH was 5.2%. Significant associations were observed with male sex, older age, and prior GH. High-grade MH was linked to increased GU cancer risk, emphasizing the importance of followup even in patients with low-grade MH, with prioritization given to those with high-grade MH.

Downloads

Download data is not yet available.

Downloads

Published

2026-03-30

How to Cite

Keramati, S., Mousa, A., Fathy, M., Mehrnoush, V., Tatangelo, M., Ghaffarimarandi, N., … Elmansy, H. (2026). Genitourinary malignancy among patients presenting with microscopic hematuria in Northwestern Ontario. Canadian Urological Association Journal, 20(8). https://doi.org/10.5489/cuaj.9469

Issue

Vol. 20 No. 8 (2026): CUAJ August

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.